Precision Medicine Group (PMG) provides specialized services and an integrated infrastructure to support pharmaceutical and life-sciences companies developing precision-medicine drugs and diagnostics. The company supports development, approval and commercialization efforts across drugs and diagnostics. PMG was formed in 2012 and is headquartered in Bethesda, Maryland, with more than 1,000 employees and 22 locations in the U.S., Canada and Europe. Management says the company’s services address key challenges facing biopharmaceutical and diagnostic companies. The new capital will fund expansion of PMG’s global footprint and provide additional scale to accelerate development and commercial success for customers. No revenue or other financial metrics were disclosed in the article.

Total raised

$275M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2017